CEST
Taking place from 23 to 27 October 2026 in Madrid, ESMO Congress 2026 is one of the leading global platforms for oncology research, clinical practice, and patient care.
As part of the congress, Gene Solutions will bring this important conversation to the global oncology community through our Industry Satellite Symposium:
The symposium reflects Gene Solutions’ mission to make precision cell-free DNA testing accessible to millions of people across the cancer care continuum, so more people can receive an answer in time to act.
Leave your details now to stay up to date with the latest scientific findings and insights, with early and complimentary access to Gene Solutions’ Industry Satellite Symposium at ESMO Congress 2026.
One symposium will bring together six expert perspectives on what it takes to move from innovation to evidence, from evidence to implementation, and from precision science to impact at scale.
Leave your details now and stay tuned for access to exclusive scientific insights from Gene Solutions’ Industry Satellite Symposium at ESMO Congress 2026.
Gene Solutions is a global biotechnology company applying its precision cell-free DNA platform, together with multi-omics and artificial intelligence, to improve pregnancy care, cancer detection and precision medicine.
The company works with healthcare providers, researchers and institutions to broaden access to clinically meaningful genomic innovation.
